In July 2020, the Emergency Command Center of the Economic and Information Technology Department of Sichuan Province sent a letter of appreciation to our company, expressing their profound respect and sincere gratitude for the work and support provided by our company during the COVID-19 pandemic.

Upon learning of the sudden outbreak of the 2019-nCoV, as an important producer of Human Immunoglobulin (pH4) for Intravenous Injection, our company has always put the safety and health of the people first. We have taken the initiative to fulfill our social responsibility and actively responded to the call of the Central Committee, the State Council, the provincial Party committee, and the provincial government. We have fully committed ourselves to the battle against the 2019-nCoV, with "guaranteeing the supply of medical supplies" as a key focus. At the end of January 2020, our company rapidly initiated pandemic prevention and control measures, organized our employees to resume work and production, and became one of the earliest and largest companies in the Chengdu High-tech Zone to resume operations. Despite the challenges of shortages of pandemic prevention materials during the Chinese New Year, disrupted logistics transportation, and material shortages, all employees of the company actively joined the forefront of pandemic prevention and control, working at full capacity, overtime, and selflessly, effectively ensuring the supply of drugs during the pandemic prevention and control period. Moreover, none of the more than 1,800 employees of the company have been infected. Due to the inability of third-party cold chain suppliers to provide transportation during the pandemic period, our company urgently arranged for charter vehicles to deliver 30,000 vials of "Human Immunoglobulin (pH4) for Intravenous Injection" to Wuhan. During the pandemic prevention and control period, our company has sent a total of 440,000 vials of Human Immunoglobulin (pH4) for Intravenous Injection to Wuhan, Hubei, Chongqing, Zhejiang, and other areas on multiple occasions. We have also exported 40,000 vials of Human Immunoglobulin (pH4) for Intravenous Injection to other relevant countries, contributing to the global battle against pandemic prevention and control.

A letter of thanks, filled with the spirit of battling the pandemic The steady streams merge into rivers and seas, and every piece of love gathers into great compassion. This letter of thanks fully recognizes the achievements of Sichuan Yuanda Shuyang, and reflects the loving and warm brand image of the company. We express our gratitude to all our partners and employees for their contributions in overcoming difficulties and ensuring the supply of essential medicines for pandemic prevention and control! Currently, the domestic situation of pandemic prevention and control is improving, with the accelerating recovery of production and daily life order. However, the international situation of pandemic prevention and control remains severe. In the face of challenges, Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. will continue to unite and move forward, turning pressure into motivation, focusing on blood products, collaborating in the field of biopharmaceuticals, and making greater contributions to the high-quality development of the Chinese economy while effectively combating the pandemic!